Journal article
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Abstract
BACKGROUND: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain.
OBJECTIVE: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients with warfarin-associated coagulopathy.
Authors
Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S
Journal
Annals of Internal Medicine, Vol. 150, No. 5, pp. 293–300
Publisher
American College of Physicians
Publication Date
March 3, 2009
DOI
10.7326/0003-4819-150-5-200903030-00005
ISSN
1056-8751